Steven Schwartz, MD

Steven Schwartz, Ahmanson Professor of Ophthalmology, Stein Eye Institute is a recognized expert in the translational research with a successful track record including contributions to the anti-vascular endothelial growth factor therapeutics, drug delivery systems, vitreoretinal diagnostic imaging instrumentation, novel therapeutic lasers and surgical devices including a novel microsurgical robotic system. Currently he is leading the first clinical trials of human embryonic stem cell derived RPE transplanted into patients with Age Related Macular Degeneration and Stargardt macular degeneration. He has just received an IND to study human embryonic stem cell therapeutics in pathologic myopia. His research is widely published with over 100 peer-reviewed publications including the lead article on the first in human successful stem cell therapy in the Lancet.